Tag Archives: technology

RESI on MaRS – Spotlight Your Technology in the RESI Innovation Challenge

2 Feb

By Shaoyu Chang, MD, MPH, Director of Research & Asia Business Development Liaison, LSN

Shaoyu 10*10

LSN is gearing up for the upcoming Redefining Early Stage Investments (RESI) Conference in Toronto’s MaRS Discovery District, and we’re seeking fundraising CEOs with the most promising early stage healthcare technologies to showcase in the RESI Innovation Challenge on April 4, 2017.

LSN’s scientific team is preparing to review the RESI Innovation Challenge applications from therapeutics, medtech, diagnostics and healthcare IT companies around the globe. All applicants will be vetted based on not only the quality of the company’s scientific work, but also the strength of the management team and how well-positioned the company is to receive investment.

On April 4, 2017, each attendee will receive “RESI Cash” to allocate to the entrepreneurs whose technologies they expect will be most influential. The capital invested will be tallied up and the top three winners will receive prizes and be featured in our RESI newsletter recap that will go out to LSN’s 20,000 newsletter readership. See below for the previous RESI Innovation Challenge first place winners – a diverse group of startups from every area of the life sciences.

What makes the RESI Innovation Challenge so valuable?  We’ve included a few words from previously successful participants below, but in short, being part of the Innovation Challenge provides startups with a new way to get attention and start dialogues with the investors who attend RESI. Participants can share their message all day in the exhibit hall, with their Innovation Challenge display providing a starting point for a meaningful conversation about the opportunity.

apply-button

APPLICATION DEADLINE: FEB. 15, 2017

Here is what our previous winners are saying about the RESI Innovation Challenge:

DSC00392

“It was an absolute pleasure to participate in the RESI conference held at MaRS in Toronto. The unique structure of the conference facilitated creating new relationships with potential investors and partners. In particular, the Innovation Challenge pushed us to introduce ourselves to new people, which will be useful as we look towards a future financing round. I definitely recommend the RESI conferences to entrepreneurs seeking financing in the bio / health space.”
 
– Raymond Shih, President, Co-Founder, QoC Health
3rd Place, RESI on MaRS, June 23, 2016

“I love the RESI Innovation Challenge because it is a great way to give our pitch to practice it and try to obtain a scarce resource from these investors. Practicing with these investors is a great way to build relationships and continue that on to the real investment conversations.”

– Niko Skievaski, Co-Founder, Redox

1st Place, RESI@TMCx, June 8, 2015

02

“The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space.  It’s a good showcase to reach that audience.”

– Jessica Ching, CEO, Eve Medical

2nd Place, RESI San Francisco, January 12, 2016

“The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings.”

– John Connolly, VP Corporate Development, Rna Diagnostics

1st Place, RESI Boston, September 16, 2015

01

“RESI offers small companies like GeneSegues a direct line to potential partners and potential investors in a small setting conducive to relationship building and conversation. The Innovation Challenge was a particularly great way to introduce our company to a broader audience than I could meet with personally which allowed us to leverage the showcasing of our technology more efficiently.”

-Laura M. Brod，Chief Executive Officer，GeneSegues Therapeutics

-1st Place, RESI @TMCx, April 11, 2016

Tags: , , ,

Compelling New Technology Startups Selected, RESI X Innovation Challenge

18 Aug

By Dennis Ford, CEO of LSN; Creator of RESI Conference Series

As RESI comes back to Boston for its 10th conference, we’re excited to announce the early stage life science companies that will be participating in the event’s RESI Innovation Challenge.

The 30 participating companies have been hand-selected by LSN’s scientific review committee based on the innovative nature of their core technology and how well-positioned each is to capitalize on their respective market opportunities. The selected companies, two thirds of which have received funding from various NIH institutes, cover all corners of the life science domain including therapeutics, medtech, diagnostics and digital health.

Therapeutics

ADT-500t Duophos-500t Laurent-Pharmaceuticals-500t
Mitochondrial-Substrate-Invention-500t Novoron-500t PrimeVax-500t
SignalRx-500t

Technology Platform

Diagnostics

Medical Device

Digital Health

Tags: , , , , ,

RESI on MaRS: Spotlight Your Technology in the MaRS HealthKick Innovation Challenge

21 Apr

By Jay Doherty, Marketing Manager, LSN

jay

LSN is gearing up for our first international RESI event in Toronto on June 23rd, and we’re seeking the most promising early stage healthcare technologies to showcase in the MaRS HealthKick Innovation Challenge. Successful applicants will be showcased in an exhibition-style format throughout the full-day conference.

LSN’s internal scientific review board will choose the top 30 applicant companies to present their technologies. Presenters will gain exposure to investors and potential partners by showcasing their companies and products in a poster board format in the RESI Exhibition Hall. Unlike traditional 5- to 15-minute pitch presentations, which don’t provide any real one-on-one interaction or actionable feedback from investors, the MaRS HealthKick Innovation Challenge enables executives to share their pitch directly with attendees, which can generate more in-depth and frequent conversations with potential investors throughout the event.

To add some friendly competition to the mix, LSN invites all attendees to participate in the MaRS HealthKick Innovation Challenge as virtual investors. At the start of the day, each attendee will receive “RESI Cash” to allocate to the entrepreneurs whose technologies they expect will be most successful. The capital invested will be tallied up at the end of the day, and the top three winners will receive prizes and be featured in our RESI newsletter recap that will go out to LSN’s 23,000 newsletter readership.

Previous RESI Innovation Challenge winners include:

Please apply to the MaRS HealthKick Innovation Challenge today to put the spotlight on your company. We look forward to seeing you take part in our first RESI on MaRS!

MARS-Innovation-Challenge

Tags: , , ,

Adapting Your Start-up to the Investor Mindset

12 Dec

By Max Klietmann, VP of Marketing, LSN

LSN spends a lot of time speaking with both investors and early stage life science executives. One of the constant themes in our experience is the disconnect between what investors want to see when evaluating companies, and the way in which early stage executives present themselves. Though there is a broad spectrum of elements that influence an investor’s decision to allocate, there is only a handful of factors that can make or break an investor dialogue early on. If you, as an early stage entrepreneur, understand how to address these points up front, you are likely to see significantly higher success in your fundraising efforts:

  • Competent Management – A racecar is only as good as its driver. Similarly, a technology without excellent management is dead in the water. Savvy investors invest in people, and the ones that have been around the block are able to see if a CEO has what it takes. Take a look at yourself and your team – the scientific acumen is undoubtedly there, but take a hard look at the business acumen and sales ability of your management team – do they have what it takes? If not, find someone who can drive, while you engineer.
  • Technology – This is a big one, whether your technology is a disruptive innovation or an iterative improvement to existing technology. Learn to explain your product succinctly, and be able to tell an investor exactly how it fills a demonstrated market need. Show investors the nature of your technology – showcase it, and explain why the competition doesn’t stand a chance in your slice of the marketplace.
  • Focused Approach – It’s easy to get caught up in the potential applications of your technology, but this can be a pitfall. Many CEO’s are eager to show all of the diseases that could be addressable by their small molecule, but it translates to a lack of focus from an investor standpoint. Don’t get me wrong – having backup plans in your back pocket is always a good thing, but pick one product, one indication, and show your investor prospect that you have the laser focus to get it done.
  • The right target population – We’ve spoken about knowing your marketplace at length. Do your research, and make sure you are targeting the right population from your investor audience’s standpoint. Are you a solution for a broad indication with lots of prospective customers, or are you better suited for the shortened regulatory path around a niche orphan disease? Choose one and be able to explain why your product is the hottest thing to hit this area.
  • A clear path to market – Have a roadmap for your regulatory path and key partners to help you move forward. Nothing is ever set in stone, and things will constantly change, but it means a great deal to an investor that you aren’t only thinking of stepping from A to B, but C, D & E are also being considered in your present decision making.

At the end of the day, you need to sell each prospective investor on these points. There will always be further criteria to discuss and deal terms to navigate, but in order to have the ability to choose investors, you need to have a relationship with several. Meet these key points, and you should be well on your way to raising a round on terms that fit your company’s needs.

Tags: ,

Newer Entries →